Cargando…

Response of remission lymphocytes to autochthonous leukaemic myeloblasts.

Thymidine incorporation in vitro by remission lymphocytes from a total of 6 patients with acute myeloid leukaemia (AML) was measured following stimulation by autochthonous and allogeneic AML blasts and cell lines. The early peak response to autochthonous blasts in 2 of these patients (48-72 h) is co...

Descripción completa

Detalles Bibliográficos
Autores principales: Taylor, G. M., Freeman, C. B., Harris, R.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1976
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2024968/
https://www.ncbi.nlm.nih.gov/pubmed/1064430
_version_ 1782136668068773888
author Taylor, G. M.
Freeman, C. B.
Harris, R.
author_facet Taylor, G. M.
Freeman, C. B.
Harris, R.
author_sort Taylor, G. M.
collection PubMed
description Thymidine incorporation in vitro by remission lymphocytes from a total of 6 patients with acute myeloid leukaemia (AML) was measured following stimulation by autochthonous and allogeneic AML blasts and cell lines. The early peak response to autochthonous blasts in 2 of these patients (48-72 h) is consistent with the concept of a population of lymphocytes pre-immunized to antigens carried by the blasts. Although stimulation in one patient was increased in the presence of more stimulating (S) blasts than responding (R) lymphocytes, positive responses in other tests were obtained at an S : R ratio of 1 : 1-5. When different methods of treatment of the stimulating autochthonous blasts were compared with untreated cells, mitomycin C gave the highest stimulation indices 2 out of 3 tests. Tissue culture medium in which autochthonous blasts had been incubated for 3-5 days failed to stimulate either remission lymphocytes alone, or combined cultures of lymphocytes with autochthonous or allogeneic blasts, suggesting that mitogenic factors released from autochthonous blasts are not responsible for lymphocyte stimulation. Treatment of autochthonous or allogeneic AML blasts with glycine-HC1(pH 3-0) to remove putative "blocking" factors failed to increase the stimulatory capacity of the leukaemic blasts.
format Text
id pubmed-2024968
institution National Center for Biotechnology Information
language English
publishDate 1976
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-20249682009-09-10 Response of remission lymphocytes to autochthonous leukaemic myeloblasts. Taylor, G. M. Freeman, C. B. Harris, R. Br J Cancer Research Article Thymidine incorporation in vitro by remission lymphocytes from a total of 6 patients with acute myeloid leukaemia (AML) was measured following stimulation by autochthonous and allogeneic AML blasts and cell lines. The early peak response to autochthonous blasts in 2 of these patients (48-72 h) is consistent with the concept of a population of lymphocytes pre-immunized to antigens carried by the blasts. Although stimulation in one patient was increased in the presence of more stimulating (S) blasts than responding (R) lymphocytes, positive responses in other tests were obtained at an S : R ratio of 1 : 1-5. When different methods of treatment of the stimulating autochthonous blasts were compared with untreated cells, mitomycin C gave the highest stimulation indices 2 out of 3 tests. Tissue culture medium in which autochthonous blasts had been incubated for 3-5 days failed to stimulate either remission lymphocytes alone, or combined cultures of lymphocytes with autochthonous or allogeneic blasts, suggesting that mitogenic factors released from autochthonous blasts are not responsible for lymphocyte stimulation. Treatment of autochthonous or allogeneic AML blasts with glycine-HC1(pH 3-0) to remove putative "blocking" factors failed to increase the stimulatory capacity of the leukaemic blasts. Nature Publishing Group 1976-05 /pmc/articles/PMC2024968/ /pubmed/1064430 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Research Article
Taylor, G. M.
Freeman, C. B.
Harris, R.
Response of remission lymphocytes to autochthonous leukaemic myeloblasts.
title Response of remission lymphocytes to autochthonous leukaemic myeloblasts.
title_full Response of remission lymphocytes to autochthonous leukaemic myeloblasts.
title_fullStr Response of remission lymphocytes to autochthonous leukaemic myeloblasts.
title_full_unstemmed Response of remission lymphocytes to autochthonous leukaemic myeloblasts.
title_short Response of remission lymphocytes to autochthonous leukaemic myeloblasts.
title_sort response of remission lymphocytes to autochthonous leukaemic myeloblasts.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2024968/
https://www.ncbi.nlm.nih.gov/pubmed/1064430
work_keys_str_mv AT taylorgm responseofremissionlymphocytestoautochthonousleukaemicmyeloblasts
AT freemancb responseofremissionlymphocytestoautochthonousleukaemicmyeloblasts
AT harrisr responseofremissionlymphocytestoautochthonousleukaemicmyeloblasts